Magair-S (Magnesium Oxide)

Magnesium oxide releases magnesium ions after it dissolves in the gastrointestinal tract. The ions are absorbed and become essential cofactors in many enzymatic processes, support nerve and muscle function, and raise gastric pH by neutralizing acid. Unabsorbed magnesium draws water into the colon, softening stool and promoting bowel movements.

The appropriate dose of Magair‑S is set by the prescribing healthcare professional based on the individual’s magnesium status, underlying condition, renal function, and other concurrent medications. No fixed regimen is provided here; the prescriber tailors the amount to achieve therapeutic goals while minimizing side effects.

Magair‑S may be used during pregnancy or lactation only when the potential benefit outweighs any possible risk. Because magnesium status is important for fetal development, a healthcare provider should evaluate the need and monitor levels. Breastfeeding mothers should also seek medical advice before use.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Magair‑S. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Magair‑S provides magnesium in the oxide form, which has a high elemental magnesium content but lower bioavailability compared with chelated forms such as magnesium citrate. It is particularly useful when a strong antacid effect or laxative action is desired, whereas other salts may be preferred for rapid absorption.

Store Magair‑S at ambient temperature, preferably below 25 °C, in its original packaging. Keep the container tightly closed, protect it from moisture and direct sunlight, and keep it out of reach of children. No refrigeration is required for this oral tablet formulation.

Magair‑S is taken orally, usually with a full glass of water. The prescriber may advise taking it with food or on an empty stomach depending on the intended use, such as for antacid effect or laxative action. Tablets should be swallowed whole and not chewed or crushed unless directed.

The most serious risks include hypermagnesemia, which can lead to muscle weakness, hypotension, and cardiac arrhythmias, and severe allergic reactions that may cause rash, swelling or breathing difficulties. Patients with impaired kidney function are particularly vulnerable and should be monitored closely.

Magair‑S should be avoided in individuals with known hypersensitivity to magnesium oxide, severe renal failure, existing hypermagnesemia, or those taking medications that could cause dangerous electrolyte disturbances without medical supervision. Pregnant or breastfeeding women should only use it under professional guidance.